Evidence map›Paper›PMID 39697707›Full record

ArticleTranslational cancer research2024

The expression and prognostic value of

Jiawang Cao, Qipeng Zhang, Yiwen Xuan, Zhuan Ou, Qinghua Yu, Daoqi Zhu, Enwu Xu

Abstract read
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Frontiers in genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiawang Cao *Department of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Qipeng Zhang *Department of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Yiwen XuanDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Zhuan OuDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Qinghua YuDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Daoqi ZhuDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.
Enwu XuDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, People's Liberation Army, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is a malignancy for which the incidence and mortality rates are among the highest worldwide. This study aimed to look for potential biomarkers that affect the prognosis of patients with ESCC. Methods: The target gene Results: Gene Expression Omnibus (GEO) detected 279 differentially expressed genes (DEGs) in ESCC and paracancerous tissues. Cluster analysis and enrichment analysis showed that cluster 4 played an important role in immune-related functions. PPI network analysis showed that Conclusions:

Indexed as

esophageal squamous cell carcinoma (ESCC)hub geneIFIT3prognosis

Identifiers

PMID39697707
PMCPMC11651788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.